Spotlight -

PBMI Innovators|

2026 State of Pharmacy survey results available now|

Our July 2026 issue

News|Articles|June 30, 2026

THE GLP-1 CHALLENGE

Newsletter

Get the latest industry news, event updates and more from Managed Healthcare Executive.

Related Content

Long-Term Repigmentation Outcomes With OPZELURA® (Ruxolitinib) Cream 1.5% in Nonsegmental Vitiligo Regardless of Baseline Disease Activity

August 7th 2026

Sponsored Content

Bempedoic Acid in the 2026 ACC/AHA Multisociety Dyslipidemia Guideline

July 21st 2026

Sponsored Content

Health Begins at Home: Why Housing Has Become a Strategic Priority for Managed Care

ByAimée K. Dailey, president of Government Health Benefits at Elevance Health

July 20th 2026

Sponsored Content

Modernizing Pharmacy Benefit Administration: Addressing Legacy System Friction for Health Plans

ByJessin Joseph, PharmD, MBA, VP PBA Markets, Capital Rx

July 8th 2026

Sponsored

The Hidden Cost of Manual Chart Retrieval: How Automation Improves Data Exchange and Value-Based Care Performance

June 23rd 2026

Sponsored Content

Latest CME

Show Me Your Care Plan!™ Navigating ADC Therapies: Oncology Nursing Strategies for Optimal Patient Management

Show Me Your Care Plan!™ Navigating ADC Therapies: Oncology Nursing Strategies for Optimal Patient Management

August 24, 2026

𝘔𝘌𝘛 Alterations in NSCLC: Applying Diagnostic Advances and Targeted Therapies in a New Era of Treatment

𝘔𝘌𝘛 Alterations in NSCLC: Applying Diagnostic Advances and Targeted Therapies in a New Era of Treatment

Jonathan Goldman, MD; Sanja Dacic, MD, PhD; Deborah Doroshow, MD, PhD; Anne S. Tsao, MD, MBA

27th Annual International Lung Cancer Congress®

27th Annual International Lung Cancer Congress®

Roy S. Herbst, MD, PhD; Sandip Patel, MD, FASCO; Heather A. Wakelee, MD, FASCO

Advances in Managing EGFR-Mutant NSCLC: Applying Evidence Across the Disease Continuum

Advances in Managing EGFR-Mutant NSCLC: Applying Evidence Across the Disease Continuum

Tina Cascone, MD, PhD; Christina Baik, MD, MPH; David Planchard, MD, PhD

20th Annual New York Lung Cancers Symposium®

20th Annual New York Lung Cancers Symposium®

Balazs Halmos, MD, MS; Jamie Chaft, MD

Cases and Conversations™: Transforming Small Cell Lung Cancer Treatment Through Emerging Evidence and Expert Insights

Cases and Conversations™: Transforming Small Cell Lung Cancer Treatment Through Emerging Evidence and Expert Insights

Charles M. Rudin, MD, PhD; Anne Chiang, MD, PhD, FASCO; Jacob M. Sands, MD

Hot Seat: Converging Lines in the Management of RAS-Altered Cancers

Hot Seat: Converging Lines in the Management of RAS-Altered Cancers

Shubham Pant, MD, MBBS; Alison Schram, MD; Helena Yu, MD

From Clue to Care: Rapid Recognition and Coordinated Management of Paraneoplastic LEMS in SCLC

From Clue to Care: Rapid Recognition and Coordinated Management of Paraneoplastic LEMS in SCLC

Millie Das, MD; Wade Iams, MD, MSCI; Ruham Nasany, MD

From Suspicion to Stabilization: Early Recognition and Treatment of Paraneoplastic LEMS

From Suspicion to Stabilization: Early Recognition and Treatment of Paraneoplastic LEMS

Charu Aggarwal, MD, MPH, FASCO; Erminia Massarelli, MD, PhD, MS; Ruham Nasany, MD

Show Me the Data™: Incorporating the Latest Advances in Immunotherapy and EGFR-Targeted Treatments for Resectable, Early-Stage NSCLC

Show Me the Data™: Incorporating the Latest Advances in Immunotherapy and EGFR-Targeted Treatments for Resectable, Early-Stage NSCLC

Mara Antonoff, MD, FACS; Laura Alder, MD; Stephanie Worrell, MD, FACS

Trending on Managed Healthcare Executive

New hypertension drugs show no advantage over older generics

Noninvasive imaging of basal cell carcinoma: Examining the choices

Inaccurate data in provider directories is costing health plans. Why a national provider diectory and data science are the fix

Physicians may be the key for affordable healthcare

Conversations with Perry and Friends: Dipak Patek, CEO of Globo